← Leaderboards
Rajeev Vibhakar
University Of Colorado Denver
$7,603,339
Attributed
$7,603,339
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,603,339 · 5
By mechanism
R01$6,359,138 · 3
K08$844,371 · 1
R21$399,830 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Erika T Brown$508,794
- Cynthia Neill Epperson$17,042,197
- Tracy L Bale$25,675,397
- Carol A Kruse$3,200,645
- Diana M. Cittelly$3,958,321
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoTumorCellsMediatingTranslationsMedulloblastomaMalignant Neoplasm Of BrainMorbidity - Disease RateTumorigenesisChildChildhood Brain NeoplasmIn VitroChemotherapyValidationClinically RelevantPre-ClinicalSubgroupGenomicsClinical TrialsTreatment EfficacyNerve Stem CellTherapeutic TargetMolecularMouse Model
Grant awards (27)
Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastoma$383,359
R01 · FY2025 · NS · contact PI
Selective targeting of ependymoma progenitor cells via BMI1 inhibition$181,741
R21 · FY2025 · CA · contact PI
Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastoma$419,996
R01 · FY2024 · NS · contact PI
Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastoma$427,202
R01 · FY2023 · NS · contact PI
Selective targeting of ependymoma progenitor cells via BMI1 inhibition$218,089
R21 · FY2023 · CA · contact PI
Mechanisms of resistance to WEE1 inhibition in Myc driven medulloblastoma$407,702
R01 · FY2022 · NS · contact PI
Targeting Wee1 in Myc driven Medulloblasoma$255,118
R01 · FY2019 · NS · contact PI
Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma$346,576
R01 · FY2018 · NS · contact PI
Role of EZH2 in Medulloblastoma Tumorigenesis$340,156
R01 · FY2018 · NS · contact PI
Targeting Wee1 in Myc driven Medulloblasoma$255,118
R01 · FY2018 · NS · contact PI
Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma$346,576
R01 · FY2017 · NS · contact PI
Role of EZH2 in Medulloblastoma Tumorigenesis$340,156
R01 · FY2017 · NS · contact PI
Targeting Wee1 in Myc driven Medulloblasoma$255,118
R01 · FY2017 · NS · contact PI
Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma$346,576
R01 · FY2016 · NS · contact PI
Role of EZH2 in Medulloblastoma Tumorigenesis$340,156
R01 · FY2016 · NS · contact PI
Targeting Wee1 in Myc driven Medulloblasoma$255,118
R01 · FY2016 · NS · contact PI
Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma$346,576
R01 · FY2015 · NS · contact PI
Role of EZH2 in Medulloblastoma Tumorigenesis$340,156
R01 · FY2015 · NS · contact PI
Targeting Wee1 in Myc driven Medulloblasoma$254,913
R01 · FY2015 · NS · contact PI
Polo-Like Kinase 1 as a Therapeutic Target in Medulloblastoma$359,503
R01 · FY2014 · NS · contact PI
Role of EZH2 in Medulloblastoma Tumorigenesis$339,063
R01 · FY2014 · NS · contact PI
Brain Enriched MicroRNA 128a and 9/9+: Impact on medulloblastoma pathogenesis$187,380
K08 · FY2013 · NS · contact PI
Brain Enriched MicroRNA 128a and 9/9+: Impact on medulloblastoma pathogenesis$161,569
K08 · FY2012 · NS · contact PI
Brain Enriched MicroRNA 128a and 9/9+: Impact on medulloblastoma pathogenesis$163,510
K08 · FY2011 · NS · contact PI
Brain Enriched MicroRNA 128a and 9/9+: Impact on medulloblastoma pathogenesis$165,488
K08 · FY2010 · NS · contact PI
Brain Enriched MicroRNA 128a and 9/9+: Impact on medulloblastoma pathogenesis$110,819
K08 · FY2008 · NS · contact PI
Brain Enriched MicroRNA 128a and 9/9+: Impact on medulloblastoma pathogenesis$55,605
K08 · FY2008 · NS · contact PI